New York is currently home to 4473 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Recruiting
The purpose of this study is to 1) determine whether it is feasible to measure circulating tumor DNA (ctDNA) in real-time during standard treatment for newly diagnosed diffuse large B-cell lymphoma (DLBCL), and 2) evaluate the outcomes of participants with undetectable ctDNA in the middle of treatment who receive a shortened course of chemotherapy. There are no investigational drug agents to be administered in this study. The investigational assay, phased variant enrichment and detection sequen... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/14/2025
Locations: Columbia University, New York, New York
Conditions: Lymphoma, Lymphoma, B-Cell, Diffuse Large B Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High-grade B-cell Lymphoma
Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients
Recruiting
Limited data exist describing the use and role of vibrators in a urogynecology population and no randomized controlled trials investigating the use of vibrators as a therapeutic tool to enhance sexual and pelvic floor function in urogynecology patients has been conducted. This study aims to evaluate the efficacy of vibrator use in improving sexual and pelvic floor function in urogynecology patients who report sexual dysfunction.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
01/14/2025
Locations: Albany Medical Center, Albany, New York
Conditions: Pelvic Floor Dysfunction, Sexual Dysfunction Female, Vibrator
Synbiotic Therapy for NP-PASC
Recruiting
Gut microbiome dysbiosis has been noted in patients with Post-acute sequelae (PASC) of Severe Acute Respiratory Syndrome-CoronaVirus -2 (SARS-CoV-2). A study performed at Columbia found that plasma levels of the short chain fatty acid (SCFA), butyric acid, remained lower in people with Neuropsychiatric PASC (NP-PASC) than in people with PASC after SAR-CoV-2 infection. Synbiotics improve SCFA levels and are well-tolerated in the general population but have not been studied among people with PASC... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/14/2025
Locations: Columbia University Irving Medical Center, New York, New York
Conditions: Post-Acute COVID-19 Syndrome, Long COVID-19
Graded Insulin Suppression Test P&F
Recruiting
The goal of this study is to learn about how the hormone insulin controls blood sugar in a variety of people. The main question it aims to answer is about how much insulin the body actually needs to maintain a normal blood sugar level. Participants will be asked to come in for a one-day study visit in which they will undergo a "graded insulin suppression test" ("GIST"). The GIST involves intravenous (into the vein) infusions of octreotide, a medication that turns off the body's own production of... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
01/14/2025
Locations: Columbia University Irving Medical Center, New York, New York
Conditions: Insulin Resistance, Hyperinsulinemia, Obesity, Healthy
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults with Brain Tumors
Recruiting
Recent advances in technology have allowed for the detection of cell-free DNA (cfDNA). cfDNA is tumor DNA that can be found in the fluid that surrounds the brain and spinal cord (called cerebrospinal fluid or CSF) and in the blood of patients with brain tumors. The detection of cfDNA in blood and CSF is known as a "liquid biopsy" and is non-invasive, meaning it does not require a surgery or biopsy of tumor tissue. Multiple studies in other cancer types have shown that cfDNA can be used for diagn... Read More
Gender:
ALL
Ages:
40 years and below
Trial Updated:
01/14/2025
Locations: Memorial Sloan Kettering Cancer Center, New York, New York
Conditions: Anaplastic Astrocytoma, Diffuse Brainstem Glioma, Glioblastoma Multiforme, High-grade Astrocytoma NOS, Fibrillary Astrocytoma, Low-Grade Astrocytoma, Nos, Pilocytic Astrocytoma, Choroid Plexus Carcinoma, CNS Primary Tumor, Nos, Atypical Teratoid/Rhabdoid Tumor, Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, Ependymoma, NOS, Anaplastic Oligodendroglioma, Oligodendroglioma, Nos, CNS Germ Cell Tumor, Pineoblastoma, Diffuse Leptomeningeal Glioneuronal Tumor
Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
Recruiting
This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
Gender:
ALL
Ages:
Between 75 years and 100 years
Trial Updated:
01/14/2025
Locations: NYU Langone Health, New York, New York
Conditions: Ischemic Heart Disease
Psilocybin Therapy in Advanced Cancer
Recruiting
The purpose of this research is to study the safety and effects of single-dose psilocybin 25mg versus an active placebo (single dose niacin 100mg) in the treatment of anxiety, depression, and existential distress (i.e., loss of meaning and hope; fear of death) in advanced cancer (i.e., stage 3 or 4). Study medications will be administered in conjunction with brief psychotherapy that is designed to treat anxiety, depression and existential distress in advanced cancer.
Gender:
ALL
Ages:
Between 21 years and 100 years
Trial Updated:
01/14/2025
Locations: NYU Langone Health, New York, New York
Conditions: Advanced Cancer
Level of Physical Activity and Fear Learning
Recruiting
The proposed experimental study will be the first to investigate whether exercise vs. sitting enhances consolidation of extinction learning in adults with high AS and anxiety disorders, and the mechanistic pathways of expectancy, affect, and key stress response markers.
Gender:
ALL
Ages:
Between 18 years and 60 years
Trial Updated:
01/14/2025
Locations: NYU Langone Health, New York, New York
Conditions: Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Recruiting
A study to evaluate if the randomized addition of venetoclax to a chemotherapy backbone (fludarabine/cytarabine/gemtuzumab ozogamicin \[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse who are unable to receive additional anthracyclines, or in 2nd relapse.
Gender:
ALL
Ages:
Between 29 days and 21 years
Trial Updated:
01/14/2025
Locations: Columbia University Irving Medical Center, New York, New York
Conditions: Acute Myeloid Leukemia
Promoting Health Through Play Program: Improving Parent and Child Outcomes
Recruiting
This project aims to assess the feasibility of an intervention program consisting of parent online group sessions in addition to guided individual play session between parent, child, and occupational therapy student (OTS) or an occupational therapist (OT). The investigators speculate that the Promoting Health Through Play Opportunities program will be effective in improving: 1. Parent ability to support their child's playfulness as measured during 15-minute video-recorded joint play activity a... Read More
Gender:
ALL
Ages:
Between 3 years and 5 years
Trial Updated:
01/13/2025
Locations: Head Start, New York, New York
Conditions: Child Development, Parenting
Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery
Recruiting
The proposed study seeks to understand how the cervical spinal cord should be stimulated after injury through short-term physiology experiments that will inform a preclinical efficacy trial. The purpose of this study is to determine which cervical levels epidural electrical stimulation (EES) should target to recruit arm and hand muscles effectively and selectively in spinal cord injury (SCI).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/13/2025
Locations: Columbia University Irving Medical Center, New York, New York
Conditions: Cervical Spinal Cord Injury, Tetraplegia/Tetraparesis, Cervical Myelopathy
The Hyalex Early Feasibility Study (EFS)
Recruiting
The Hyalex Early Feasibility Study is a prospective, multicenter, open-label, single-arm, 2-phase early feasibility study to evaluate the safety and technical performance of the HYALEX Knee Cartilage System for replacement of loss of articular cartilage and bone of the knee femoral condyles in symptomatic patients who require surgical treatment, will be enrolled in the study and undergo implantation of the HYALEX Knee Implant.
Gender:
ALL
Ages:
Between 21 years and 70 years
Trial Updated:
01/13/2025
Locations: Hospital for Special Surgery, New York, New York
Conditions: Cartilage Injury, Cartilage Damage